🇺🇸 FDA
Patent

US 8715968

Methods and reagents for modulating cholesterol levels

granted A61KA61K2039/53A61K38/00

Quick answer

US patent 8715968 (Methods and reagents for modulating cholesterol levels) held by Xenon Pharmaceuticals Inc. expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/53, A61K38/00, A61K48/00, A61P